AutoGPU vs Genomi

AutoGPU and Genomi are both agent frameworks tracked by AIDiveForge. Below is a side-by-side comparison of pricing, capabilities, platforms, and ownership — sourced from each tool's live website and verified before publishing.

AutoGPU

The repo describes autonomous agents writing RTL, running it through real EDA tools, reading timing and layout reports, and revising the design — iterating without a human in the seat for each pass. The documented target is small systolic array architectures, specifically matrix-multiply accelerators; the codebase includes ISA definitions, physical design configs, and golden reference models. At that constrained scope, researchers report the agent loop closes. Scale the design complexity beyond what the existing module hierarchy covers and the agents lose the plot — the feedback loops that work for a mac array do not generalize to a multi-block SoC. Teams pushing past the documented scope end up writing their own agent scaffolding on top, at which point AutoGPU is a reference rather than a runtime.

Genomi

The core workflow is four steps: install the agent harness, point it at your raw genome file on disk, build a local SQLite index, then ask questions through whichever AI agent you already run — Claude Code, Cursor, Gemini CLI, Goose, and others are listed as compatible. Pharmacogenomics, carrier status, polygenic risk scores, nutrigenomics, and ancestry PCA projection are all covered through distinct skill modules backed by ClinVar, PharmCAT, PGS Catalog, HPO, GenCC, and 1000 Genomes reference data. The privacy architecture is explicit: raw genome data stays on disk, and only the specific evidence snippets relevant to a query cross the boundary to whatever LLM handles the response. The vendor marks this as experimental and not for clinical use — which means researchers and privacy-conscious individuals exploring personal data are the intended audience, not clinical teams expecting diagnostic-grade output.

Attribute	AutoGPU	Genomi
Pricing	Free	Free
Free trial	No	No
Open source	Yes	Yes
Has API	No	No
Self-hosted option	Yes	Yes
Platforms	—	Linux, macOS, Windows (Python-based)
Released	2026-06	2024
Pros	Full-stack agentic loop from RTL generation through physical layout hardening, so you avoid the manual handoff between code generation and EDA execution that makes most LLM hardware tools a partial solution. Ships with ISA definitions, module RTL, and golden reference models for matrix-multiply accelerators, which means the agent has structured domain context on day one rather than hallucinating architecture details from scratch. Entirely open-source with no paid-only features, so the full agent scaffolding, EDA integration hooks, and design configs are auditable and forkable — no black-box inference calls gating the loop. Self-hosted by default, which means your RTL, timing reports, and design IP stay on your own infrastructure rather than transiting a vendor's API. Iterative revision loop reads real EDA output — timing reports, layout feedback — and feeds it back into the agent, so design errors surface and get corrected inside the automated loop rather than piling up for a human review session.	Local-first data architecture keeps the raw genome file on disk and only sends queried evidence snippets to the LLM, so teams with strict data policies can explore personal genomic data without uploading a single variant to a third-party server. Skill modules cover pharmacogenomics via PharmCAT and ClinPGx, carrier status via ClinVar and HPO, polygenic risk via PGS Catalog, and ancestry via 1000 Genomes PCA — so a researcher doesn't have to stitch together five separate tools and manually reconcile their outputs. Each answer carries source attribution and stated evidence limits, which means you can trace a finding back to ClinVar or GenCC rather than accepting a response with no provenance — a real gap in generic LLM genomic Q&A. Agent-agnostic MCP and skills-host architecture plugs into whichever AI agent a team already runs, so there is no forced migration to a new interface or locked-in model provider. Apache-2.0 open-source license with self-hosted deployment means developers building agent-based genomic analysis tools can inspect, modify, and extend the skill layer without negotiating commercial terms.
Cons	The agent's planning and feedback parsing are scoped to the existing module hierarchy — small systolic arrays and mac structures. When a design introduces module types outside that vocabulary, the agent loses coherent planning context and the loop stalls or produces nonsense RTL; teams at that point are extending the framework from source, not using it. No API surface and no abstraction layer between the agent and the raw EDA toolchain means EDA tool version changes or environment differences break the agent loop silently; debugging requires tracing through agent execution logs and EDA stdout, not a structured error interface. Star and fork counts from the repository indicate this is an early-stage research artifact with a single primary contributor — community-reported workarounds, tested configurations, and maintained documentation are sparse, so teams that hit an undocumented edge case have the source code and nothing else. Teams needing a maintained, production-grade EDA automation layer with active support will move to a commercial EDA vendor's scripting environment instead.	Installation requires following a source-code setup guide and configuring an AI agent to connect to the harness — non-technical users hit a wall before they ask a single question, and there is no hosted web interface to fall back on. The project is vendor-labeled experimental, which means skill coverage, reference database freshness, and edge-case handling are not production-guaranteed; teams relying on consistent outputs for any regulated or clinical-adjacent workflow will find the absence of validation documentation disqualifying and will move to a certified clinical genomics platform instead. There is no hosted API, so teams building products that need to serve genomic queries to end users must provision and maintain their own infrastructure — at scale, that maintenance burden is not accounted for in the zero-cost licensing. Evidence snippets sent to an external LLM during a query still cross a data boundary, even if the raw genome file stays local; teams operating under strict genomic data agreements need to verify that snippet-level transmission satisfies their compliance posture before deploying, and the tool provides no compliance documentation to support that review.

Bottom line

AutoGPU and Genomi are closely matched on pricing model, openness, and API availability — pick by feature set and platform support in the table above.

Frequently asked questions

What is the difference between AutoGPU and Genomi?

AutoGPU is Free and open source, while Genomi is Free and open source. Compare pricing, free trial, API, platforms, and pros/cons in the table above on AIDiveForge.

Is AutoGPU better than Genomi?

It depends on your workflow. Use the side-by-side attributes (pricing, open source, API, self-hosted, platforms) to decide. AIDiveForge does not rank a universal winner — we publish verified facts so you can choose.